Skip to main content
Erschienen in: Head and Neck Pathology 4/2021

02.04.2021 | Original Paper

Oropharyngeal Squamous Cell Carcinoma Morphology and Subtypes by Human Papillomavirus Type and by 16 Lineages and Sublineages

verfasst von: James S. Lewis Jr., Lisa Mirabello, Ping Liu, Xiaowei Wang, William D. Dupont, W. Dale Plummer, Maisa Pinheiro, Meredith Yeager, Joseph F. Boland, Michael Cullen, Mia Steinberg, Sara Bass, Mitra Mehrad, Connor O’Boyle, Maoxuan Lin, Daniel L. Faden, Krystle A. Lang-Kuhs

Erschienen in: Head and Neck Pathology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Oropharyngeal squamous cell carcinoma (SCC) is increasing in incidence and, in Western countries, strongly associated with transcriptionally-active high-risk human papillomavirus (HPV). Within HPV-positive tumors, there is wide morphologic diversity with numerous histologic subtypes of SCC. There are also variable degrees of keratinization, anaplasia, stromal fibrosis, and maturing squamous differentiation. Unlike in the uterine cervix, where associations between HPV types and lineages/sublineages within types have been investigated with some clear correlations identified, little to no data exists for oropharyngeal SCC. In this study, for a large cohort of oropharyngeal SCC patients, we performed RTPCR for high-risk HPV. For the HPV positive patients, we sequenced the DNA of the entire HPV16 genome and determined lineages and sublineages, correlating HPV status, genotype, and HPV16 lineages/sublineages with SCC subtype and various histologic features. Of the 259 patients, 224 (86.5%) were high-risk HPV positive, of which 210/224 (93.8%) were HPV type 16 and 6/224 (2.7%) HPV type 33. Of the four HPV16 lineages, A was the most frequent (192/214 or 89.8%) and of the HPV16 A sublineages, A1 was the most frequent (112/210 or 53.3%). Patients with HPV negative tumors were more often keratinizing vs other types (23/35 or 65.7%) and thus more likely to have more maturing squamous differentiation and stromal desmoplasia. There was no significant correlation between HPV type (16 versus other), between HPV16 lineage (A versus others), or HPV16 A sublineages (A1 or A2 versus others) and morphologic type of SCC nor the various morphologic features of anaplasia/multinucleation, degree of keratinization, nor amount of stromal desmoplasia. In summary, in our cohort, there was no correlation between the type of HPV, the HPV 16 lineage or sublineage, and any of the histologic features or morphologic SCC subtypes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.CrossRef Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.CrossRef
2.
Zurück zum Zitat Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Instit. 2008;100:261–9.CrossRef Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Instit. 2008;100:261–9.CrossRef
3.
Zurück zum Zitat Gillison ML, Chaturvedi AK, Anderson WF, et al. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol: Off J Am Soc Clin Oncol. 2015;33:3235–42.CrossRef Gillison ML, Chaturvedi AK, Anderson WF, et al. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol: Off J Am Soc Clin Oncol. 2015;33:3235–42.CrossRef
4.
Zurück zum Zitat Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Instit. 2000;92:709–20.CrossRef Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Instit. 2000;92:709–20.CrossRef
5.
Zurück zum Zitat Burk RD, Harari A, Chen Z. Human papillomavirus genome variants. Virology. 2013;445:232–43.CrossRef Burk RD, Harari A, Chen Z. Human papillomavirus genome variants. Virology. 2013;445:232–43.CrossRef
6.
Zurück zum Zitat Mirabello L, Clarke MA, Nelson CW, et al. The Intersection of HPV epidemiology, genomics and mechanistic studies of HPV-mediated carcinogenesis. Viruses. 2018;10:80.CrossRef Mirabello L, Clarke MA, Nelson CW, et al. The Intersection of HPV epidemiology, genomics and mechanistic studies of HPV-mediated carcinogenesis. Viruses. 2018;10:80.CrossRef
7.
Zurück zum Zitat Mirabello L, Yeager M, Cullen M, et al. HPV16 sublineage associations with histology-specific cancer risk using hpv whole-genome sequences in 3200 women. J Natl Cancer Inst. 2016;108. Mirabello L, Yeager M, Cullen M, et al. HPV16 sublineage associations with histology-specific cancer risk using hpv whole-genome sequences in 3200 women. J Natl Cancer Inst. 2016;108.
8.
Zurück zum Zitat Coutlee F, Ratnam S, Ramanakumar AV, et al. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol. 2011;83:1034–41.CrossRef Coutlee F, Ratnam S, Ramanakumar AV, et al. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol. 2011;83:1034–41.CrossRef
9.
Zurück zum Zitat Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88:63–73.CrossRef Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88:63–73.CrossRef
10.
Zurück zum Zitat Insinga RP, Liaw KL, Johnson LG, et al. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008;17:1611–22.CrossRef Insinga RP, Liaw KL, Johnson LG, et al. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008;17:1611–22.CrossRef
11.
Zurück zum Zitat O'Sullivan B, Lydiatt WM, Haughey BH, et al. HPV-Mediated (p16+) Oropharyngeal Cancer. In: Amin MB, ed. AJCC Cancer Staging Manual. Switzerland: Springer Nature; 2016. O'Sullivan B, Lydiatt WM, Haughey BH, et al. HPV-Mediated (p16+) Oropharyngeal Cancer. In: Amin MB, ed. AJCC Cancer Staging Manual. Switzerland: Springer Nature; 2016.
12.
Zurück zum Zitat Danciu I, Cowan JD, Basford M, et al. Secondary use of clinical data: the vanderbilt approach. J Biomed Inform. 2014;52:28–35.CrossRef Danciu I, Cowan JD, Basford M, et al. Secondary use of clinical data: the vanderbilt approach. J Biomed Inform. 2014;52:28–35.CrossRef
13.
Zurück zum Zitat WHO Classification of Head and Neck Tumours. In: El-Naggar A, Chan JKC, Grandis JR, et al., eds. Lyon, France: IARC Press; 2017. WHO Classification of Head and Neck Tumours. In: El-Naggar A, Chan JKC, Grandis JR, et al., eds. Lyon, France: IARC Press; 2017.
14.
Zurück zum Zitat Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis JS Jr. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol. 2009;3:186–94.CrossRef Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis JS Jr. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol. 2009;3:186–94.CrossRef
15.
Zurück zum Zitat Gondim DD, Haynes W, Wang X, et al. Histologic typing in oropharyngeal squamous cell carcinoma: a 4-year prospective practice study with p16 and high-risk HPV mrna testing correlation. Am J Surg Pathol. 2016;40:1117–24.CrossRef Gondim DD, Haynes W, Wang X, et al. Histologic typing in oropharyngeal squamous cell carcinoma: a 4-year prospective practice study with p16 and high-risk HPV mrna testing correlation. Am J Surg Pathol. 2016;40:1117–24.CrossRef
16.
Zurück zum Zitat Chernock RD. Morphologic features of conventional squamous cell carcinoma of the oropharynx: “keratinizing” and “nonkeratinizing” histologic types as the basis for a consistent classification system. Head Neck Pathol. 2012;6(Suppl 1):S41-47.CrossRef Chernock RD. Morphologic features of conventional squamous cell carcinoma of the oropharynx: “keratinizing” and “nonkeratinizing” histologic types as the basis for a consistent classification system. Head Neck Pathol. 2012;6(Suppl 1):S41-47.CrossRef
17.
Zurück zum Zitat Lewis JS Jr, Khan RA, Masand RP, et al. Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma - a prospective cohort and interobserver variability study. Histopathology. 2012;60:427–36.CrossRef Lewis JS Jr, Khan RA, Masand RP, et al. Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma - a prospective cohort and interobserver variability study. Histopathology. 2012;60:427–36.CrossRef
18.
Zurück zum Zitat Cardesa A, Zidar N, Alos L. Adenosquamous carcinoma. In: Barnes L, Eveson J, Reichart P, Sidransky D, editors. Pathology and Genetics Head and Neck Tumours. Lyon, France: IARC Press; 2005. p. 130–1. Cardesa A, Zidar N, Alos L. Adenosquamous carcinoma. In: Barnes L, Eveson J, Reichart P, Sidransky D, editors. Pathology and Genetics Head and Neck Tumours. Lyon, France: IARC Press; 2005. p. 130–1.
19.
Zurück zum Zitat Cardesa A, Zidar N, et al. Spindle cell carcinoma. In: Barnes EL, Eveson JW, Reichart P, et al., editors. World Health Organization Pathology and Genetics - Head and Neck Tumours. Lyon, France: IARC Press; 2005. p. 127–8. Cardesa A, Zidar N, et al. Spindle cell carcinoma. In: Barnes EL, Eveson JW, Reichart P, et al., editors. World Health Organization Pathology and Genetics - Head and Neck Tumours. Lyon, France: IARC Press; 2005. p. 127–8.
20.
Zurück zum Zitat Cardesa A, Zidar N, Ereno C, et al. Basaloid squamous cell carcinoma. In: Barnes EL, Eveson JW, Reichart P, et al., editors. World Health Organization Classification of Tumours - Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC Press; 2005. p. 125–6. Cardesa A, Zidar N, Ereno C, et al. Basaloid squamous cell carcinoma. In: Barnes EL, Eveson JW, Reichart P, et al., editors. World Health Organization Classification of Tumours - Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC Press; 2005. p. 125–6.
21.
Zurück zum Zitat Cardesa A, Zidar N, Nadal A, et al. Papillary squamous cell carcinoma. In: Barnes L, eveson JW, Reichart P, et al., eds. World Health Organization Classification of Tumours - Pathology and Genetics Head and Neck Tumours. Lyon, France: IARC Press. 2005;126. Cardesa A, Zidar N, Nadal A, et al. Papillary squamous cell carcinoma. In: Barnes L, eveson JW, Reichart P, et al., eds. World Health Organization Classification of Tumours - Pathology and Genetics Head and Neck Tumours. Lyon, France: IARC Press. 2005;126.
22.
Zurück zum Zitat Singhi AD, Stelow EB, Mills SE, et al. Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma. Am J Surg Pathol. 2010;34:800–5.CrossRef Singhi AD, Stelow EB, Mills SE, et al. Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma. Am J Surg Pathol. 2010;34:800–5.CrossRef
23.
Zurück zum Zitat Lewis JS Jr, Scantlebury JB, Luo J, et al. Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancers. Am J Surg Pathol. 2012;36:1036–46.CrossRef Lewis JS Jr, Scantlebury JB, Luo J, et al. Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancers. Am J Surg Pathol. 2012;36:1036–46.CrossRef
24.
Zurück zum Zitat Gao G, Chernock RD, Gay HA, et al. A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis. Int J Cancer J Int du Cancer. 2013;132:882–90.CrossRef Gao G, Chernock RD, Gay HA, et al. A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis. Int J Cancer J Int du Cancer. 2013;132:882–90.CrossRef
25.
Zurück zum Zitat Cullen M, Boland JF, Schiffman M, et al. Deep sequencing of HPV16 genomes: a new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. Papillomavirus Res. 2015;1:3–11.CrossRef Cullen M, Boland JF, Schiffman M, et al. Deep sequencing of HPV16 genomes: a new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. Papillomavirus Res. 2015;1:3–11.CrossRef
26.
Zurück zum Zitat Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics. 2006;22:2688–90.CrossRef Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics. 2006;22:2688–90.CrossRef
27.
Zurück zum Zitat Jordan RC, Lingen MW, Perez-Ordonez B, et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol. 2012;36:945–54.CrossRef Jordan RC, Lingen MW, Perez-Ordonez B, et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol. 2012;36:945–54.CrossRef
28.
Zurück zum Zitat Baricevic I, He X, Chakrabarty B, et al. High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis. Eur J Cancer. 2015;51:776–85.CrossRef Baricevic I, He X, Chakrabarty B, et al. High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis. Eur J Cancer. 2015;51:776–85.CrossRef
Metadaten
Titel
Oropharyngeal Squamous Cell Carcinoma Morphology and Subtypes by Human Papillomavirus Type and by 16 Lineages and Sublineages
verfasst von
James S. Lewis Jr.
Lisa Mirabello
Ping Liu
Xiaowei Wang
William D. Dupont
W. Dale Plummer
Maisa Pinheiro
Meredith Yeager
Joseph F. Boland
Michael Cullen
Mia Steinberg
Sara Bass
Mitra Mehrad
Connor O’Boyle
Maoxuan Lin
Daniel L. Faden
Krystle A. Lang-Kuhs
Publikationsdatum
02.04.2021
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 4/2021
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-021-01318-4

Weitere Artikel der Ausgabe 4/2021

Head and Neck Pathology 4/2021 Zur Ausgabe

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …